Yu Tian

机构：Zhejiang Sci-Tech University, Xuzhou Medical College, Chinese Academy of Sciences, AbbVie (United States), Shanghai Institute of Applied Physics, Peking University Shenzhen Hospital, Huizhou Central People's Hospital, University of Chinese Academy of Sciences, AbbVie (Japan) · ORCID：0000-0003-3847-4378

发表论文 33 篇 · 总被引 419 次 · h-index 12

代表论文

• Sensitive and specific detection of breast cancer lymph node metastasis through dual-modality magnetic particle imaging and fluorescence molecular imaging: a preclinical evaluation (2022 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 55)
• MiR-130a-3p regulates FUNDC1-mediated mitophagy by targeting GJA1 in myocardial ischemia/reperfusion injury (2023 · Cell Death Discovery · 被引 36)
• Peptide-Based Double-Network Hydrogels for Melanoma Treatment and Wound Healing Promotion (2023 · ACS Applied Materials & Interfaces · 被引 31)
• Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis (2024 · Frontiers in Immunology · 被引 25)
• miR-153-3p Targets βII Spectrin to Regulate Formaldehyde-Induced Cardiomyocyte Apoptosis (2021 · Frontiers in Cardiovascular Medicine · 被引 20)
• HIF-1α Mediates Immunosuppression and Chemoresistance in Colorectal Cancer by Inhibiting CXCL9, −10 and −11 (2024 · Biomedicine & Pharmacotherapy · 被引 18)